Vistara -Single-Gene NIPT
FromNatera, Inc.
Vistara is the most comprehensive prenatal single-gene screening test for serious genetic conditions. These conditions, which affect quality of life, could benefit from early intervention and might otherwise go undetected. Vistara tests for 25 serious genetic conditions with a blood draw from the mother. Most results will be returned to a clinician within 2-3 weeks.
Most popular related searches
blood collection
prenatal screening test
clinical data
prenatal screen
prenatal screening
prenatal testing
prenatal test
Vistara, single-gene NIPT, enables deeper insights for better health outcomes
- Screen for 25 autosomal dominant and X-linked conditions across 30 genes with Vistara single-gene NIPT
- Combined incidence greater than Down syndrome1,2
- Provide clinically actionable information
- Many single-gene conditions benefit from early intervention
- Inform decisions for pregnancy and delivery management, early interventions, and patient education to ensure every child reaches their full potential
- Perform testing with ease and get clear results
- No paternal and/or egg-donor* sample necessary
- Find conditions other screening modalities would miss until after the window for critical intervention
*if applicable